Refining clinical decision strategies and prostate cancer detection through fine adjustments in the combination of PSA-derived parameters and MRI
- PMID: 38683387
- DOI: 10.1007/s00330-024-10734-3
Refining clinical decision strategies and prostate cancer detection through fine adjustments in the combination of PSA-derived parameters and MRI
Comment on
-
Reduction of false positives using zone-specific prostate-specific antigen density for prostate MRI-based biopsy decision strategies.Eur Radiol. 2024 Oct;34(10):6229-6240. doi: 10.1007/s00330-024-10700-z. Epub 2024 Mar 28. Eur Radiol. 2024. PMID: 38538841 Free PMC article.
References
-
- Padhani AR, Godtman RA, Schoots IG (2024) Key learning on the promise and limitations of MRI in prostate cancer screening. Eur Radiol. https://doi.org/10.1007/s00330-024-10626-6
-
- Walker SM, Mehralivand S, Harmon SA et al (2020) Prospective evaluation of PI-RADS version 2.1 for prostate cancer detection. AJR Am J Roentgenol 215(5):1098–1103. https://doi.org/10.2214/AJR.19.22679 - DOI - PubMed - PMC
-
- Hamm C, Baumgärtner GL, Padhani A et al (2024) Reduction of false positives using zone-specific prostate-specific antigen density for prostate MRI-based biopsy decision strategies. Eur Radiol. https://doi.org/10.1007/s00330-024-10700-z
-
- Washino S, Okochi T, Saito K et al (2017) Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients BJU Int 119(2):225–233. https://doi.org/10.1111/bju.13465 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
